Deeks, Emma D <br/><br/>
Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection.  [electronic resource] 

 -  Drugs  Feb 2014 
 - 195-206 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.1007/s40265-013-0160-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Atazanavir Sulfate<br/>Carbamates--adverse effects<br/>Cobicistat<br/>Cytochrome P-450 CYP3A--metabolism<br/>Cytochrome P-450 CYP3A Inhibitors--adverse effects<br/>Darunavir<br/>Drug Synergism<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--pharmacokinetics<br/>HIV-1--drug effects<br/>Humans<br/>Oligopeptides--pharmacokinetics<br/>Pyridines--pharmacokinetics<br/>Sulfonamides--pharmacokinetics<br/>Thiazoles--adverse effects